{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:25:19Z","timestamp":1778869519306,"version":"3.51.4"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:00:00Z","timestamp":1536105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica, Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","award":["PICT 2010 N\u00b0 2148, PICT 2013 N\u00b0 2828"],"award-info":[{"award-number":["PICT 2010 N\u00b0 2148, PICT 2013 N\u00b0 2828"]}]},{"name":"FOCANLIS","award":["2010"],"award-info":[{"award-number":["2010"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0203462","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T13:55:23Z","timestamp":1536155723000},"page":"e0203462","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates"],"prefix":"10.1371","volume":"13","author":[{"given":"Luz P.","family":"Quebrada Palacio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariela N.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Hernandez-Vasquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina E.","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Parodi-Talice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Bua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1759-5819","authenticated-orcid":true,"given":"Miriam","family":"Postan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,9,5]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Chagas disease (American trypanosomiasis) Fact sheet 340. 2016. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/mediacentre\/factsheets\/fs340\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/mediacentre\/factsheets\/fs340\/en\/<\/ext-link>"},{"key":"ref2","unstructured":"Pan American Health Organization. Chagas disease. 2016. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.paho.org\/hq\/\" xlink:type=\"simple\">http:\/\/www.paho.org\/hq\/<\/ext-link>"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","article-title":"Long-term cardiac outcomes of treating chronic chagas disease with benznidazole versus no treatment: A nonrandomized trial","volume":"144","author":"R Viotti","year":"2006","journal-title":"Ann Intern Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized Trial of Benznidazole for Chronic Chagas\u2019 Cardiomyopathy","volume":"373","author":"CA Morillo","year":"2015","journal-title":"N Engl J Med"},{"key":"ref5","first-page":"346","article-title":"Biological variations in trypanosomes and their relation to the epidemiology of Chagas\u2019 disease","volume":"7","author":"FL Lambrecht","year":"1965","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1590\/S0074-02762009000700021","article-title":"A new consensus for <italic>Trypanosoma cruzi<\/italic> intraspecific nomenclature: second revision meeting recommends TcI to TcVI","volume":"104","author":"B Zingales","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.meegid.2011.12.009","article-title":"The revised <italic>Trypanosoma cruzi<\/italic> subspecific nomenclature: Rationale, epidemiological relevance and research applications","volume":"12","author":"B Zingales","year":"2012","journal-title":"Infect Genet Evol. Elsevier B.V."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1586\/14787210.2015.1056158","article-title":"Between a bug and a hard place: <italic>Trypanosoma cruzi<\/italic> genetic diversity and the clinical outcomes of Chagas disease","volume":"13","author":"L a Messenger","year":"2015","journal-title":"Expert Rev Anti Infect Ther. Informa UK, Ltd"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1007\/s00436-015-4503-2","article-title":"<italic>Trypanosoma cruzi<\/italic> burden, genotypes, and clinical evaluation of Chilean patients with chronic Chagas cardiopathy","volume":"114","author":"W Apt","year":"2015","journal-title":"Parasitol Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0000687","article-title":"Lineage analysis of circulating <italic>Trypanosoma cruzi<\/italic> parasites and their association with clinical forms of chagas disease in Bolivia","volume":"4","author":"R Del Puerto","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1017\/S0031182011002186","article-title":"<italic>Trypanosoma cruzi<\/italic> Discrete Typing Units in Chagas disease patients from endemic and non-endemic regions of Argentina","volume":"139","author":"CI Cura","year":"2012","journal-title":"Parasitology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1128\/IAI.00193-16","article-title":"TcI isolates of <italic>Trypanosoma cruzi<\/italic> exploit the antioxidant network for enhanced intracellular survival in macrophages and virulence in mice","volume":"84","author":"MP Zago","year":"2016","journal-title":"Infect Immun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.actatropica.2012.05.003","article-title":"Biological behavior of different <italic>Trypanosoma cruzi<\/italic> isolates circulating in an endemic area for Chagas disease in the Gran Chaco region of Argentina","volume":"123","author":"PG Ragone","year":"2012","journal-title":"Acta Trop. Elsevier B.V."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0002069","article-title":"<italic>Trypanosoma cruzi<\/italic> I and IV Stocks from Brazilian Amazon Are Divergent in Terms of Biological and Medical Properties in Mice","volume":"7","author":"WM Monteiro","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.exppara.2008.09.012","article-title":"<italic>Trypanosoma cruzi<\/italic>: Genetic diversity influences the profile of immunoglobulins during experimental infection","volume":"121","author":"DM d Santos","year":"2009","journal-title":"Exp Parasitol. Elsevier Inc."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1038\/srep04703","article-title":"Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against <italic>Trypanosoma cruzi<\/italic>: implications for Chagas disease drug discovery and development","volume":"4","author":"CB Moraes","year":"2014","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040901","article-title":"Differential trypanocidal activity of novel macrolide antibiotics; correlation to genetic lineage","volume":"7","author":"C Aquilino","year":"2012","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0020-7519(01)00238-7","article-title":"Characterisation of large and small subunit rRNA and mini-exon genes further supports the distinction of six <italic>Trypanosoma cruzi<\/italic> lineages","volume":"31","author":"S Brisse","year":"2001","journal-title":"Int J Parasitol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4269\/ajtmh.2009.09-0305","article-title":"Genotyping of <italic>Trypanosoma cruzi<\/italic>: Systematic selection of assays allowing rapid and accurate discrimination of all known lineages","volume":"81","author":"MD Lewis","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399402004118","article-title":"Chagas disease: role of parasite genetic variation in pathogenesis","volume":"4","author":"AM Macedo","year":"2002","journal-title":"Expert Rev Mol Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.7705\/biomedica.v29i3.15","article-title":"<italic>In vitro<\/italic> susceptibility of <italic>Trypanosoma cruzi<\/italic> strains from Santander, Colombia, to hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole","volume":"29","author":"KP Luna","year":"2009","journal-title":"Biomedica"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"K Katsuno","year":"2015","journal-title":"Nat Rev Drug Discov. Nature Publishing Group"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1021\/pr700659m","article-title":"Proteomic analysis of <italic>Trypanosoma cruzi<\/italic> resistance to benznidazole","volume":"7","author":"HM Andrade","year":"2008","journal-title":"J Proteome Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0166-6851(98)00127-3","article-title":"Overexpression of superoxide dismutase in <italic>Trypanosoma cruzi<\/italic> results in increased sensitivity to the trypanocidal agents gentian violet and benznidazole","volume":"96","author":"NJ Temperton","year":"1998","journal-title":"Mol Biochem Parasitol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.actatropica.2006.10.004","article-title":"Increased expression of iron-containing superoxide dismutase-A (TcFeSOD-A) enzyme in <italic>Trypanosoma cruzi<\/italic> population with <italic>in vitro<\/italic>-induced resistance to benznidazole","volume":"100","author":"FB Nogueira","year":"2006","journal-title":"Acta Trop"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0035-9203(80)90252-7","article-title":"Delimitation of <italic>Trypanosoma cruzi<\/italic> zymodemes by numerical taxonomy","volume":"74","author":"PD Ready","year":"1980","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0166-6851(00)00302-9","article-title":"Identification of six <italic>Trypanosoma cruzi<\/italic> lineages by sequence-characterised amplified region markers","volume":"111","author":"S Brisse","year":"2000","journal-title":"Mol Biochem Parasitol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e1049","DOI":"10.1371\/journal.pntd.0001049","article-title":"Multilocus sequence typing (MLST) for lineage assignment and high resolution diversity studies in <italic>Trypanosoma cruzi<\/italic>","volume":"5","author":"M Yeo","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.actatropica.2015.05.006","article-title":"The population genetics of <italic>Trypanosoma cruzi<\/italic> revisited in the light of the predominant clonal evolution model","volume":"151","author":"M Tibayrenc","year":"2015","journal-title":"Acta Trop. Elsevier B.V."},{"key":"ref30","article-title":"<italic>Trypanosoma cruzi<\/italic> genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity","author":"B Zingales","year":"2017","journal-title":"Acta Trop. Elsevier B.V."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.meegid.2014.11.001","article-title":"<italic>Trypanosoma cruzi<\/italic> diversity in the Gran Chaco: Mixed infections and differential host distribution of TcV and TcVI","volume":"29","author":"MM Monje-Rumi","year":"2015","journal-title":"Infect Genet Evol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/infdis\/jis331","article-title":"Benznidazole-resistance in <italic>Trypanosoma cruzi<\/italic> is a readily acquired trait that can arise independently in a single population","volume":"206","author":"AM Mejia","year":"2012","journal-title":"J Infect Dis"},{"key":"ref33","first-page":"63","article-title":"Comparison of infectivity of strains of <italic>Trypanosoma cruzi<\/italic> (Chagas, 1909)","volume":"56","author":"DE Bice","year":"1970","journal-title":"J Parasitol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1051\/parasite\/1983584317","article-title":"<italic>Trypanosoma cruzi<\/italic>: attenuation of virulence by culture in tissues","volume":"58","author":"S Urdaneta-Morales","year":"1983","journal-title":"Ann Parasitol Hum Comp"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cbpa.2006.03.004","article-title":"Mode of action of natural and synthetic drugs against <italic>Trypanosoma cruzi<\/italic> and their interaction with the mammalian host","volume":"146","author":"JD Maya","year":"2007","journal-title":"Comp Biochem Physiol\u2014A Mol Integr Physiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e2844","DOI":"10.1371\/journal.pntd.0002844","article-title":"Benznidazole biotransformation and multiple targets in <italic>Trypanosoma cruzi<\/italic> revealed by metabolomics","volume":"8","author":"A Trochine","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"13088","DOI":"10.1074\/jbc.M111.230847","article-title":"Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites","volume":"286","author":"BS Hall","year":"2011","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0135556","article-title":"Antiprotozoal activity profiling of approved drugs: A starting point toward drug repositioning","volume":"10","author":"M Kaiser","year":"2015","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejmech.2011.12.010","article-title":"Analogs of pentamidine as potential anti-<italic>Pneumocystis<\/italic> chemotherapeutics","volume":"48","author":"D MacIejewska","year":"2012","journal-title":"Eur J Med Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actatropica.2014.02.012","article-title":"Pentamidine exerts <italic>in vitro<\/italic> and <italic>in vivo<\/italic> anti <italic>Trypanosoma cruzi<\/italic> activity and inhibits the polyamine transport in <italic>Trypanosoma cruzi<\/italic>","volume":"134","author":"M V D\u00edaz","year":"2014","journal-title":"Acta Trop"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: pharmacological actions beyond anti-malarial","volume":"142","author":"WE Ho","year":"2014","journal-title":"Pharmacol Ther"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1128\/AAC.01544-06","article-title":"Artemisinins inhibit <italic>Trypanosoma cruzi<\/italic> and <italic>Trypanosoma brucei rhodesiense in vitro<\/italic> growth","volume":"51","author":"Y V Mishina","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0035-9203(88)90208-8","article-title":"Comparative studies of drug susceptibility of five strains of <italic>Trypanosoma cruzi in vivo<\/italic> and <italic>in vitro<\/italic>","volume":"82","author":"RA Neal","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0035-9203(87)90020-4","article-title":"Susceptibility and natural resistance of <italic>Trypanosoma cruzi<\/italic> strains to drugs used clinically in Chagas disease","volume":"81","author":"LS Filardi","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e740","DOI":"10.1371\/journal.pntd.0000740","article-title":"<italic>In vitro<\/italic> and <italic>in vivo<\/italic> high-throughput assays for the testing of anti-<italic>Trypanosoma cruzi<\/italic> compounds","volume":"4","author":"AMC Canavaci","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1550-7408.1977.tb01010.x","article-title":"Growth-inhibition drug test with <italic>Trypanosoma cruzi<\/italic> culture forms","volume":"24","author":"BR Schlemper","year":"1977","journal-title":"J Protozool"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0169-4758(86)90157-2","article-title":"<italic>In vitro<\/italic> screens in the experimental chemotherapy of leishmaniasis and trypanosomiasis","volume":"2","author":"SL Croft","year":"1986","journal-title":"Parasitol Today"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1590\/S0074-02762010000700014","article-title":"<italic>Trypanosoma cruzi<\/italic> benznidazole susceptibility <italic>in vitro<\/italic> does not predict the therapeutic outcome of human Chagas disease","volume":"105","author":"M Moreno","year":"2010","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1084\/jem.20020885","article-title":"A key role for old yellow enzyme in the metabolism of drugs by <italic>Trypanosoma cruzi<\/italic>","volume":"196","author":"BK Kubata","year":"2002","journal-title":"J Exp Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jprot.2011.04.006","article-title":"Molecular characterization and interactome analysis of <italic>Trypanosoma cruzi<\/italic> tryparedoxin 1","volume":"74","author":"MD Pi\u00f1eyro","year":"2011","journal-title":"J Proteomics"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/0976-500X.72351","article-title":"Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research","volume":"1","author":"C Kilkenny","year":"2010","journal-title":"J Pharmacol Pharmacother"},{"key":"ref52","first-page":"12","article-title":"How to Improve the Early Diagnosis of <italic>Trypanosoma cruzi<\/italic> Infection: Relationship between Validated Conventional Diagnosis and Quantitative DNA Amplification in Congenitally Infected Children","volume":"7","author":"J Bua","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.abb.2012.02.020","article-title":"Tryparedoxin peroxidases and superoxide dismutases expression as well as ROS release are related to <italic>Trypanosoma cruzi<\/italic> epimastigotes growth phases","volume":"520","author":"EF Peloso","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4269\/ajtmh.1983.32.497","article-title":"Studies of <italic>Trypanosoma cruzi<\/italic> clones in inbred mice. I. A comparison of the course of infection of C3H\/HEN- mice with two clones isolated from a common source","volume":"32","author":"M Postan","year":"1983","journal-title":"Am J Trop Med Hyg"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1371\/journal.pntd.0000419","article-title":"Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients","volume":"3","author":"T Duffy","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.trstmh.2012.03.015","article-title":"Vertical transmission of <italic>Trypanosoma cruzi<\/italic> infection: quantification of parasite burden in mothers and their children by parasite DNA amplification","volume":"106","author":"J Bua","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0203462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T16:39:40Z","timestamp":1540312780000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0203462"}},"subtitle":[],"editor":[{"given":"M. Carolina","family":"Elias","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":56,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0203462","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,5]]}}}